Twenty-four-month interim results from a prospective, single-arm clinical trial evaluating the performance and safety of cellular bone allograft in patients undergoing lumbar spinal fusion

BACKGROUND: Autologous bone grafts are the gold standard for spinal fusion; however, harvesting autologous bone can result in donor site infection, hematomas, increased operative time, and prolonged pain. Cellular bone allografts (CBAs) are a viable alternative that avoids the need for bone harvesti...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Daniel K., Wind, Joshua J., Lansford, Todd, Nunley, Pierce, Peppers, Timothy A., Russo, Anthony, Hassanzadeh, Hamid, Sembrano, Jonathan, Yoo, Jung, Sales, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656884/
https://www.ncbi.nlm.nih.gov/pubmed/37978378
http://dx.doi.org/10.1186/s12891-023-06996-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656884/
https://www.ncbi.nlm.nih.gov/pubmed/37978378
http://dx.doi.org/10.1186/s12891-023-06996-5

Ejemplares similares